it is1:30am. now on bbc news click. it s the hardest problem in technology, and one that could change everything. this week, we re in arizona, the self driving capital of the world, to ride in the latest robotic vehicles. meet the people who are not happy to see them. what am i going to do then? stand in line for food? ..and to find out what happens when the tech goes wrong. when california told uber that there were going to be some new regulations they needed to adhere to, governor ducey in a public announcement said. california may not want you, we want you to know that arizona does. we are a state that is open for business. welcomes business and new people and technology. our governor, governor ducey, had basically opened wide - the arms of our state . to welcome them there and it was a no brainer. chandler is a hub where - autonomous vehicles are growing and having more miles mapped on our roads than any- place else in the galaxy. it s kind great to bel in the centre of
it has just it hasjust gone it has just gone to 30 am. now on bbc news. tuesday in parliament. hello, and welcome to tuesday in parliament. more questions over david cameron s lobbying of ministers. does the minister now agree that dave was, and indeed, remains dodgy? no. an mp sanctioned by china for speaking out about human rights abuses discovers why. apparently for maliciously spreading lies and misinformation . that is, of course, in the language of the chinese communist party, a euphemism for speaking the truth. - also in this programme: cross party tributes to a former cabinet minister. she called us all darling not because she d forgotten our names, butjust because she wanted to put everybody at their ease. but first, boris johnson is under growing pressure over the former prime minister david cameron s attempts to lobby ministers on behalf of the finance firm greensill capital, which has since gone bust. downing street has announced an inquiry into the affair,
johnson &johnson has delayed the rollout of its covid vaccine in europe after regulators in the united states called for a pause because of safety concerns. six people who d had the vaccine in the us have developed rare and severe blood clots. it s so far been given to almost seven million americans. our medical editor fergus walsh reports. an abundance of caution was cited by us health officials as the reason why they paused the use of the single shotjohnson &johnson covid jab. the vaccine, which in europe is branded as janssen, was approved in the us in late february. since then, there have been six incidents of very rare clots in the brain, out of 6.8 million doses. so less than one case per million people immunised. all were women under 50, one of them died and one is critically ill. i think this is an unusual occurrence of a serious adverse event that you want to make sure before you go forward, you investigate it thoroughly. and that s exactly what they re doing. they r
johnson &johnson has delayed the rollout of its covid vaccine in europe after regulators in the united states called for a pause because of safety concerns. six people who d had the vaccine in the us have developed rare and severe blood clots. it s so far been given to almost seven million americans. our medical editor fergus walsh reports. an abundance of caution was cited by us health officials as the reason why they paused the use of the single shotjohnson &johnson covid jab. the vaccine, which in europe is branded as janssen, was approved in the us in late february. since then, there have been six incidents of very rare clots in the brain, out of 6.8 million doses. so less than one case per million people immunised. all were women under 50, one of them died and one is critically ill. i think this is an unusual occurrence of a serious adverse event that you want to make sure before you go forward, you investigate it thoroughly. and that s exactly what they re doing. they r
japan faces criticisms for plans to release into the sea contaminated water from the fukushima power plant. hello to you. johnson &johnson has delayed the rollout of its covid vaccine in europe. regulators in the united states had already called for a pause because of safety concerns. expedia who have had the vaccine in the us have developed rare and severe blood clots. it has so far been given to almost 7 million americans. 0ur medical editor, fergus walsh has the story. an abundance of caution was cited by us health officials as the reason why they paused the use of the single shotjohnson &johnson covid jab. the vaccine, which in europe is branded as janssen, was approved in the us in late february. since then, there have been six incidents of very rare clots in the brain, out of 6.8 million doses. so, less than one case per million people immunised. all were women under 50, one of them died and one is critically ill. i think this is an unusual occurrence of a serious adver